Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Marta Peciña, Jordan F. Karp, Sanjay J. Mathew, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 4, pp. 576-587
Open Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 257
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 230
Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis
Glenn E. Hunt, Gin S. Malhi, Harry Man Xiong Lai, et al.
Journal of Affective Disorders (2020) Vol. 266, pp. 288-304
Closed Access | Times Cited: 197
The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression
Eleni Pitsillou, Sarah M. Bresnehan, Evan A. Kagarakis, et al.
Molecular Biology Reports (2019) Vol. 47, Iss. 1, pp. 753-770
Closed Access | Times Cited: 157
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders
Daniel B. Rosoff, George Davey Smith, Falk W. Lohoff
JAMA Psychiatry (2020) Vol. 78, Iss. 2, pp. 151-151
Open Access | Times Cited: 140
Mechanisms of ketamine and its metabolites as antidepressants
Evan Hess, Lace M. Riggs, Michael Michaelides, et al.
Biochemical Pharmacology (2021) Vol. 197, pp. 114892-114892
Open Access | Times Cited: 116
Mouse Anesthesia: The Art and Science
Kaela Navarro, Monika K Huss, Jennifer Smith, et al.
ILAR Journal (2021) Vol. 62, Iss. 1-2, pp. 238-273
Open Access | Times Cited: 110
On what motivates us: a detailed review of intrinsic v. extrinsic motivation
Laurel S. Morris, Mora M. Grehl, Sarah Rutter, et al.
Psychological Medicine (2022) Vol. 52, Iss. 10, pp. 1801-1816
Open Access | Times Cited: 92
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
Mario García‐Domínguez
Biomedicines (2025) Vol. 13, Iss. 1, pp. 165-165
Open Access | Times Cited: 2
A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks
Omer Karin, Moriya Raz, Avichai Tendler, et al.
Molecular Systems Biology (2020) Vol. 16, Iss. 7
Open Access | Times Cited: 122
The role of the opioid system in decision making and cognitive control: A review
Henk van Steenbergen, Marie Eikemo, Siri Leknes
Cognitive Affective & Behavioral Neuroscience (2019) Vol. 19, Iss. 3, pp. 435-458
Open Access | Times Cited: 102
The role of vitamin C in stress-related disorders
Bettina Moritz, Ariana Ern Schmitz, Ana Lúcia S. Rodrigues, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 85, pp. 108459-108459
Closed Access | Times Cited: 98
Mechanisms of Melatonin in Obesity: A Review
Qingyun Guan, Zixu Wang, Jing Cao, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 218-218
Open Access | Times Cited: 96
Interindividual variability and lateralization of μ-opioid receptors in the human brain
Tatu Kantonen, Tomi Karjalainen, Janne Isojärvi, et al.
NeuroImage (2020) Vol. 217, pp. 116922-116922
Open Access | Times Cited: 95
Targeting opioid dysregulation in depression for the development of novel therapeutics
Caroline A. Browne, Irwin Lucki
Pharmacology & Therapeutics (2019) Vol. 201, pp. 51-76
Open Access | Times Cited: 84
Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding
Jan‐Marino Ramirez, Nicholas Burgraff, Aguan Wei, et al.
Journal of Neurophysiology (2021) Vol. 125, Iss. 5, pp. 1899-1919
Open Access | Times Cited: 74
The opioid system in depression
Luke A. Jelen, James Stone, Allan H. Young, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104800-104800
Open Access | Times Cited: 49
Endogenous opioid systems alterations in pain and opioid use disorder
Jessica A. Higginbotham, Tamara Markovic, Nicolas Massaly, et al.
Frontiers in Systems Neuroscience (2022) Vol. 16
Open Access | Times Cited: 42
The cancer-immune dialogue in the context of stress
Yuting Ma, Guido Kroemer
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 264-281
Closed Access | Times Cited: 34
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
The endogenous opioid system in the medial prefrontal cortex mediates ketamine’s antidepressant-like actions
Cheng Jiang, Ralph Dileone, Christopher Pittenger, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Negative affectivity drivers of impulsivity in opioid use disorder
Jasmin Vassileva, Elena Psederska, James M. Bjork
Nature Reviews Psychology (2025)
Closed Access | Times Cited: 1
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
Lauri Nummenmaa, Tomi Karjalainen, Janne Isojärvi, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1953-1959
Open Access | Times Cited: 68
Non-nociceptive roles of opioids in the CNS: opioids’ effects on neurogenesis, learning, memory and affect
Cherkaouia Kibaly, Chi Xu, Catherine M. Cahill, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 1, pp. 5-18
Open Access | Times Cited: 67
Current strategies toward safer mu opioid receptor drugs for pain management
Aliza T. Ehrlich, Brigitte L. Kieffer, Emmanuel Darcq
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 4, pp. 315-326
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top